In order to examine the function of gal-1, we performed in vitro experiments to knockdown galectin-1 in CD133+ tumor cells, we found that this treatment significantly reduced tumor cells proliferation, colony formation and invasion. The gene discussed is LGALS1; the disease is neoplasm.